481 related articles for article (PubMed ID: 22630574)
21. Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia.
Banerjee S; Lei D; Liang S; Yang L; Liu S; Wei Z; Tang JP
Oncotarget; 2017 Jun; 8(24):39695-39702. PubMed ID: 27980226
[TBL] [Abstract][Full Text] [Related]
22. Molecular screening strategies for NF1-like syndromes with café-au-lait macules (Review).
Zhang J; Li M; Yao Z
Mol Med Rep; 2016 Nov; 14(5):4023-4029. PubMed ID: 27666661
[TBL] [Abstract][Full Text] [Related]
23. Value of a café-au-lait macules screening clinic: Experience from The Hospital for Sick Children in Toronto.
Albaghdadi M; Berseneva M; Pennal A; Wan S; Matviychuk D; Shugar A; Kannu P; Lara-Corrales I
Pediatr Dermatol; 2022 Mar; 39(2):205-210. PubMed ID: 35178768
[TBL] [Abstract][Full Text] [Related]
24. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
25. Multiple café au lait spots in familial patients with MAP2K2 mutation.
Takenouchi T; Shimizu A; Torii C; Kosaki R; Takahashi T; Saya H; Kosaki K
Am J Med Genet A; 2014 Feb; 164A(2):392-6. PubMed ID: 24311457
[TBL] [Abstract][Full Text] [Related]
26. [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].
Karwacki MW; Woźniak W
Med Wieku Rozwoj; 2006; 10(3 Pt 2):923-48. PubMed ID: 17401183
[TBL] [Abstract][Full Text] [Related]
27. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants.
Kehrer-Sawatzki H; Cooper DN
Hum Genet; 2022 Feb; 141(2):177-191. PubMed ID: 34928431
[TBL] [Abstract][Full Text] [Related]
28. Autosomal dominant multiple café-au-lait spots and neurofibromatosis-1: evidence of non-linkage.
Charrow J; Listernick R; Ward K
Am J Med Genet; 1993 Mar; 45(5):606-8. PubMed ID: 8456833
[TBL] [Abstract][Full Text] [Related]
29. [Diagnostics of neurofibromatosis (Recklinghausen disease)].
Ardashev VN; Seriakov AP; Nikolaeva SN; Konev AV; Smolin AV
Voen Med Zh; 2004 Jun; 325(6):41-4. PubMed ID: 15327140
[No Abstract] [Full Text] [Related]
30. Bilateral segmental neurofibromatosis: a case report and review.
Gonzalez G; Russi ME; Lodeiros A
Pediatr Neurol; 2007 Jan; 36(1):51-3. PubMed ID: 17162198
[TBL] [Abstract][Full Text] [Related]
31. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
[TBL] [Abstract][Full Text] [Related]
32. The different forms of neurofibromatosis.
Ruggieri M
Childs Nerv Syst; 1999 Jul; 15(6-7):295-308. PubMed ID: 10461778
[TBL] [Abstract][Full Text] [Related]
33. [Segmental neurofibromatosis in children. Presentation of 43 patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; López-Gutiérrez JC
Rev Neurol; 2008 Oct 16-31; 47(8):399-403. PubMed ID: 18937200
[TBL] [Abstract][Full Text] [Related]
34. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
[TBL] [Abstract][Full Text] [Related]
35. Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis.
Burkitt Wright EM; Sach E; Sharif S; Quarrell O; Carroll T; Whitehouse RW; Upadhyaya M; Huson SM; Evans DG
J Med Genet; 2013 Sep; 50(9):606-13. PubMed ID: 23812910
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic variability among café-au-lait macules in neurofibromatosis type 1.
Boyd KP; Gao L; Feng R; Beasley M; Messiaen L; Korf BR; Theos A
J Am Acad Dermatol; 2010 Sep; 63(3):440-7. PubMed ID: 20605257
[TBL] [Abstract][Full Text] [Related]
37. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
[TBL] [Abstract][Full Text] [Related]
38. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
Buteică E; Stoicescu I; Burada F; Stănoiu B
Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
[TBL] [Abstract][Full Text] [Related]
39. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.
Wimmer K; Rosenbaum T; Messiaen L
Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754
[TBL] [Abstract][Full Text] [Related]
40. Neonatal McCune-Albright Syndrome with Giant Cell Hepatitis.
Ikawa Y; Yachi Y; Inoue N; Kato A; Okajima M; Yachie A
J Pediatr; 2016 Nov; 178():298. PubMed ID: 27592093
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]